Trinity Biotech plc (TRIB) Stock Price & Analysis
Trinity Biotech plc (TRIB) closed at USD 7.93 on Thursday, October 15, 2026, up 19.97% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 6.61; the Oct 15, 2026 session ranged USD 6.21–8.36 on volume of 27,193 shares. Market capitalization is $6.45M, with a 52-week range of USD 5.01–52.5 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TRIB.md
Key facts (TRIB)
- Analysts: None.
- Total return with dividends: 1Y -74.1% vs S&P 500 +18.1%; 5Y -97.4% vs S&P 500 +85.1%.
Analysts (TRIB)
Consensus None.
Total return (dividends reinvested) (TRIB)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -74.1% | -97.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -74.2% | -51.7% |
| Volatility (annualized) | 114.1% | 87.6% |
| Max drawdown | -85.2% (Dec 2025→Oct 2026) | -98.2% (Oct 2021→Sep 2026) |
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 7.93 |
|---|---|
| Change | ▲ 19.97% (up) |
| Previous Close | USD 6.61 |
| Open | USD 6.22 |
| Day Range | USD 6.21 – 8.36 |
| 52-Week Range | USD 5.01 – 52.5 |
| Volume | 27,193 shares |
| Market Cap | $6.45M |
| Exchange | NMS |
Technical Analysis (TRIB)
Nexqual's technical model rates TRIB "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 55.05 (neutral) |
| vs SMA50 | Below (USD 8.7) |
| MACD | -0.45 (negative) |
Analyst Ratings (TRIB)
Wall Street analysts rate TRIB "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (TRIB)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-12-31 | USD -26.35 vs est -9 ▼ miss |
| 2024-09-30 | USD -12.77 vs est -16.2 ▲ beat |
| 2024-06-30 | USD -14 vs est -19.5 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (TRIB)
| Total Revenue | $43.78M |
|---|---|
| Gross Margin | +38.57% |
| Operating Margin | -9.98% |
| Profit Margin | -85.36% |
| Current Ratio | 0.25 |
| Total Cash | $5.14M |
| Total Debt | $137.98M |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financial Health Score (TRIB)
Nexqual rates Trinity Biotech plc's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 39%, operating -10% |
| Balance Sheet | Mixed — $5M cash vs $138M debt |
| Cash Flow | Weak — Operating cash flow -$6M (TTM) |
| Efficiency | Mixed — No data |
Ownership (TRIB)
| Insider Ownership | +13.81% |
|---|---|
| Institutional Ownership | +3.39% |
| Shares Outstanding | 813,132 |
| Float | 559,322 |
| Short % of Float | +5.64% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Leadership (TRIB)
Trinity Biotech plc is led by John Gillard (age 44), President, CEO, Company Secretary & Director, per Nexqual as of October 16, 2026 at 05:11 UTC.
| President, CEO, Company Secretary & Director | John Gillard (age 44) |
|---|---|
| Founder, Director & Executive Advisor | Ronan O'Caoimh A.C.A. (age 69) |
| Interim Chief Financial Officer | Paul Murphy |
| Director of Operations | Jacqueline O'Neill (age 52) |
| Chief Technology Officer | Gary Keating (age 52) |
Major Backers & Investors (TRIB)
Notable institutional backers of Trinity Biotech plc include Hunter Associates Investment Management LLC, Moss Adams Wealth Advisors LLC , Susquehanna International Group, LLP, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Hunter Associates Investment Management LLC | 2.71% |
| Moss Adams Wealth Advisors LLC | 0.11% |
| Susquehanna International Group, LLP | 0.11% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt